Purchases and Sales Made in Q2 2023 in Cyclo Therapeutics, Inc. (CYTH)
This table provides information about the institutional ownership of Cyclo Therapeutics, Inc. (CYTH) during Q2 2023. The information is specifically focused on institutions that hold shares of Cyclo Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 11, 2023
Q2 2023
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
48.1K+ 92.12% |
$32.3K - $111K
|
100K
$75.3K
|
|
|
Aug 11, 2023
Q2 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
17.8KNew |
$11.9K - $40.9K
|
17.8K
$13.4K
|
|
|
Aug 11, 2023
Q2 2023
|
Northern Trust Corp
Chicago, IL |
BUY
|
- |
16.6KNew |
$11.1K - $38.2K
|
16.6K
$12.4K
|
|
|
Aug 14, 2023
Q2 2023
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
6.5K+ 2.56% |
$4.35K - $14.9K
|
260K
$195K
|
|
|
Aug 10, 2023
Q2 2023
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
BUY
|
- |
4K+ 666.67% |
$2.68K - $9.2K
|
4.6K
$3.45K
|
|
|
Aug 15, 2023
Q2 2023
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
37+ 1.6% |
$24.8 - $85.1
|
2.35K
$1.76K
|
|
|
Aug 10, 2023
Q2 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Aug 14, 2023
Q2 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-30- 6.77% |
$20.1 - $69
|
413
$310
|
|
|
Aug 14, 2023
Q2 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-1.52K- 8.23% |
$1.02K - $3.5K
|
17K
$12.7K
|
|
|
Aug 14, 2023
Q2 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-4.82K- 40.29% |
$3.23K - $11.1K
|
7.14K
$5.35K
|